Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/beta-catenin signaling

pubmed: wnt1 2024-05-26

Summary:

CONCLUSION: These results clearly reveal a novel potential of bufalin to suppress HCC through immunomodulation, and shed light on a new M2 macrophage-based modality of HCC immunotherapy, which additively enhances direct tumor-inhibitory efficacy of bufalin.

Link:

https://pubmed.ncbi.nlm.nih.gov/38340578/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=16uwQpOeqFYN8R4TKOtwPy2utpqy9ex2oldalD2yF_fQHv2caq&fc=None&ff=20240526114848&v=2.18.0.post9+e462414

From feeds:

Exome ยป pubmed: wnt1

Tags:

Authors:

Xuemei Zhang, Xiaona Lu, Jia Shi, Yuyao Li, Yue Li, Ru Tao, Lingying Huang, Yifei Tang, Xiaojun Zhu, Man Li, Yueqiu Gao, Hai Feng, Zhuo Yu

Date tagged:

05/26/2024, 11:48

Date published:

02/10/2024, 06:00